← Back to list
IVIG (immune globulin) (Revised)
Act
by Jan 1, 2026
Effective date
Jan 1, 2026
Identified
Jun 24, 2026
Summary
Humana has revised their IVIG (immune globulin) prior authorization policy for Ohio Medicaid, effective January 1, 2026. The policy establishes preferred products and specific criteria for 24 covered conditions including primary immunodeficiency, ITP, and various autoimmune disorders.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.
Get Humana alertsPolicy Monitoring is free. No card required.
What to do
by Jan 1, 2026 · 4 steps
01Review all IVIG prescriptions for Ohio Medicaid patients to ensure they meet the specific criteria outlined in the revised policy.
02Update prior authorization procedures to use preferred products (Flebogamma DIF, Gammagard, Gammagard S/D, Gammaked, Gamunex-C, Octagam, Privigen, Hizentra, Xembify) unless patient has prior therapy or intolerance with preferred products.
03Ensure documentation includes diagnosis-specific criteria such as platelet counts for ITP or IgG levels for immunodeficiency.
04Claims may be denied without proper prior authorization.
Original notice
IVIG (immune globulin) (Revised)
mcp.humana.com · Always check the source before changing claims.
Related changes
See all Humana changes →IVIG (immune globulin) (Revised)HighEffective Jan 1, 2026 · MedicaidIVIG (immune globulin) (Revised)HighEffective Jan 1, 2026 · MedicaidIVIG (immune globulin) (Revised)HighEffective Jul 1, 2024 · MedicaidIVIG (immune globulin)HighEffective Jan 1, 2026 · MedicaidBrowse every Humana change in the policy list